Status:
COMPLETED
Arabic Gum-Absorption Study
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Bioavailability
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
Previous studies have indicated that menaquinone-7 (MK-7) is the most effective form of vitamin K. The Japanese soya product natto is one of the richest food sources of MK-7, but its taste is not appr...
Eligibility Criteria
Inclusion
- Healthy men and women aged between 20 and 40 y
- Normal body weight and height (BMI \<30 kg/m2)
- Stable body weight (weight gain or loss \<3 kg in past 3 mo)
- Caucasian race
- Written consent to take part in the study
- Low vitamin K status
Exclusion
- (A history of) metabolic or gastrointestinal diseases
- Chronic degenerative and/or inflammatory diseases
- Abuse of drugs and/or alcohol
- Use of corticosteroids
- Use of oral anticoagulants
- (A history of) soy allergy
- Use of vitamin K-containing multivitamins or vitamin K supplements
- Anaemia
- Blood donation or participation in another study within one month before the study
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT00858767
Start Date
October 1 2008
End Date
August 1 2009
Last Update
December 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VitaK BV /University of Maastricht
Maastricht, Netherlands, PO Box 616